Biotech and Pharma Market Update: Q2 2025 in Review
Jul 24, 2025 01:15PM PST
In Q2, the biotech and pharma sectors faced policy pressures as the transformative impact of AI and tariff challenges affected M&A activity and market dynamics.
Biotech Investing: World
Coverage of the biotech market for global investors, including news, analysis forecasts, and stock updates.
Latest Articles
How AI is Poised to Rewire the Foundations of Medicine
Life Science Investing NewsJun 6, 2025 09:15AM PST
More Articles
Company Profiles
IVX:AU
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
CDX:AU
Cardiex Limited
Biomarker technologies and digital solutions to address the world’s largest health disorders.
CEO Interviews
More CEO Interviews
biotech News
Appendix 4C and Quarterly Activities Report - June 2025
Pharmaceutical InvestingJul 30, 2025 09:30PM PST
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
GeographyJul 29, 2025 02:30AM PST
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
GeographyJul 28, 2025 03:00AM PST
Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
GeographyJul 22, 2025 03:00AM PST
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
GeographyJun 24, 2025 03:00AM PST
Underwritten Loyalty Option Entitlement Offer Prospectus
Pharmaceutical InvestingJun 22, 2025 05:30PM PST
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
GeographyJun 11, 2025 03:00AM PST
Editors' Picks
More Editors' Picks
